does bpc 157 cross the blood brain barrier Targeting and Crossing Blood-Brain with Extracellular Vesicles New Trends in Peptide Therapies:

The Critical Caveat All of the above is based largely on animal studies

You cannot inject the powder directly, and you cannot use just any liquid to dissolve it

PubMed Goldstein, A.L., Hannappel, E., Sosne, G., & Kleinman, H.K

Conclusion Prescriptive peptide therapies, including oral BPC-157, larazotide, KPV, and injectable thymosin beta-4, offer a groundbreaking approach to managing chronic conditions like leaky gut syndrome, IBD, celiac recovery, autoimmune diseases, and MCAS

These include the outer surface of the upper arm, the upper area of the front of the thigh, the abdomen (two inches from the belly button), and the buttocks (MedlinePlus, 2021)

For an 80 kg test subject, this would give a weekly dosage range of between 2,400-4,800 g (2.4 4.8 mg)